Emergent BioSolutions (EBS) EBT Margin (2011 - 2026)
Emergent BioSolutions (EBS) posted EBT Margin of -70.98% for Q2 2026, down 59.05 percentage points from -11.92% a year earlier and down 79.56 percentage points from the prior quarter.
Powered by 
Analysis
Emergent BioSolutions (EBS) EBT Margin (2011 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, EBT Margin at Emergent BioSolutions was -18.96%, down 41.35 percentage points year-over-year; for FY2025, it came in at 11.15%, up 24.84 percentage points from FY2024.
- Annual EBT Margin shows a five-year change of -14.97 percentage points (FY2020 to FY2025).
- In prior years, Emergent BioSolutions' EBT Margin was -13.69% in FY2024 (+55.99 pp), -69.68% in FY2023 (-50.09 pp), -19.60% in FY2022 (-36.69 pp) and 17.10% in FY2021 (-9.02 pp).
- The Q2 2026 figure stands as the lowest quarterly EBT Margin since Q2 2024.
- On a year-over-year basis, EBT Margin has declined in each of the last four quarters, with an average year-over-year change of +18.54 percentage points over the last eight quarters.
- The strongest year-over-year quarter for EBT Margin in the past five years was Q3 2024, with a gain of 146.77 percentage points; the weakest was Q1 2023, with a drop of 96.50 percentage points.
- According to Business Quant data, EBT Margin for the three prior quarters was 8.58% (Q1 2026), -34.10% (Q4 2025) and 24.92% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,146.94 Bn | 1,115.53 Bn | 19.71 Bn | 40.25% |
| 2 | Johnson & Johnson | 624.96 Bn | 543.49 Bn | 17.26 Bn | 26.66% |
| 3 | AbbVie | 510.15 Bn | 483.27 Bn | 12.70 Bn | 25.18% |
| 4 | Merck | 366.13 Bn | 320.51 Bn | 12.21 Bn | -4.11% |
| 5 | Novartis Ag | 297.75 Bn | 261.74 Bn | 11.24 Bn | 29.63% |
| 6 | Astrazeneca | 261.93 Bn | 235.62 Bn | 12.86 Bn | 18.19% |
| 7 | Amgen | 236.51 Bn | 191.91 Bn | 7.24 Bn | 27.53% |
| 8 | Gilead Sciences | 194.27 Bn | 168.47 Bn | 6.22 Bn | -131.41% |
| 9 | Pfizer | 171.74 Bn | 118.39 Bn | 10.94 Bn | -4.34% |
| 10 | Emergent BioSolutions | 325.34 Mn | -425.56 Mn | 137.20 Mn | -70.98% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -70.98% |
| Mar 31, 2026 | 8.58% |
| Dec 31, 2025 | -34.10% |
| Sep 30, 2025 | 24.92% |
| Jun 30, 2025 | -11.92% |
| Mar 31, 2025 | 41.72% |
| Dec 31, 2024 | -14.18% |
| Sep 30, 2024 | 48.47% |
| Jun 30, 2024 | -105.93% |
| Mar 31, 2024 | 4.03% |
| Dec 31, 2023 | -19.70% |
| Sep 30, 2023 | -98.30% |
| Jun 30, 2023 | -74.05% |
| Mar 31, 2023 | -97.75% |
| Dec 31, 2022 | -18.59% |
| Sep 30, 2022 | -28.01% |
| Jun 30, 2022 | -34.13% |
| Mar 31, 2022 | -1.25% |
| Dec 31, 2021 | 34.97% |
| Sep 30, 2021 | -15.89% |
API Access
Emergent BioSolutions EBT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt-margin&ticker=EBS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt-margin", "ticker": "EBS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebt-margin&ticker=EBS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();